Thursday, January 19, 2017

BRIEF-Bristol-Myers decides not to pursue accelerated regulatory pathway for combination of Opdivo plus Yervoy

* Bristol-Myers Squibb provides regulatory update in

first-line lung cancer

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)